20th Hemoglobin Switching Conference
20th Hemoglobin Switching Conference
批准号:
9197787
负责人:
James Douglas Engel
金额:
$5.5万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2017-08-31
关键词:
American Society of HematologyAnabolismBackBiochemicalBiochemistryCaliforniaCarbon DioxideCell Differentiation processCellsCellular biologyClinicalCollaborationsComplementary DNADevelopmentDevelopmental BiologyDiseaseEpigenetic ProcessErythrocytesErythropoietinEtiologyEuropeFacultyFamilyFertilizationGene Expression RegulationGeneticGenomicsGlobinGreat BritainHematologyHematopoieticHemoglobinHemoglobinopathiesHereditary DiseaseHuman CloningHuman GeneticsInheritedInternationalLungMetabolic DiseasesMetabolismMinorityMolecularMolecular BiologyMutationOxygenParticipantPhysiologyPostdoctoral FellowProcessResearchResearch PersonnelScienceScientistSiteStructureStudentsTimeTissuesWomanWorkabstractingcareerdisease phenotypeeffective therapymanmeetingsnovelphenomenological modelssuccesssymposiumtranscription factor
中文摘要
摘要
英文摘要
Abstract
The biennial Hemoglobin Switching Conference has been ongoing for 39 years, and there are
multiple reasons for its resounding success. First and foremost, the organizers (Stamatoyannopoulos,
Higgs and Engel) strive to identify and then highlight new discoveries by always including new, young
investigators and studies that impinge on the process of globin biosynthesis. Second, this is the only
venue (other than the annual ASH meeting, with more than 14,000 participants) that brings together
basic scientists and clinicians to discuss both the molecular and developmental origins of, and
treatments for, the hemoglobinopathies, the most common inherited diseases in man. Third, the
meetings have historically evolved with intense focus on wherever the science led, thus remaining
extremely topical, and has not only been the forum for presenting the first cDNA clones, the first cloned
human genomic locus (and the first mutations in same), the structure of erythropoietin and the
discovery of the GATA and KLF transcription factor families, but it has also launched the careers of
many of the current leaders in this field (indeed, numerous postdoctoral fellows and young faculty first
presented their work in plenary sessions at this conference). Fourth, this is the only meeting on this
topic that routinely has approximately equal attendance by investigators from both inside and outside
the U.S., and this fact is reflected by the biennial alternation in site between the U.S. and Europe. In
2016 the Conference will be held for the third time at the Asilomar Conference Center in California,
because of both the ease of international accessibility and economy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Michigan Kidney, Urology and Hematology Research Training Network
-
批准号:10506490
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2022
-
负责人:James Douglas Engel
-
依托单位:
Administrative Core
-
批准号:10627773
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Administrative Core
-
批准号:10164855
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Identification of novel y-globin corepressors and advanced inhibitor development
-
批准号:10164854
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Administrative Core
-
批准号:10400175
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Identification of novel y-globin corepressors and advanced inhibitor development
-
批准号:10627770
-
项目类别:
-
资助金额:$47.09万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
-
批准号:10627766
-
项目类别:
-
资助金额:$215.78万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
-
批准号:10164849
-
项目类别:
-
资助金额:$217.41万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
-
批准号:10400171
-
项目类别:
-
资助金额:$216.52万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Identification of novel y-globin corepressors and advanced inhibitor development
-
批准号:10400174
-
项目类别:
-
资助金额:$47.16万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
19th Hemoglobin Switching Conference
-
批准号:8785769
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2014
-
负责人:James Douglas Engel
-
依托单位:
The 18th Hemoglobin Switching Conference
-
批准号:8319727
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
-
批准号:8300343
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
Inactivation of LSD1 as a possible treatment for sickle cell disease
-
批准号:8319822
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
-
批准号:8416960
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
Inactivation of LSD1 as a possible treatment for sickle cell disease
-
批准号:8442767
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
-
批准号:8603835
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
Leica SPX5 2-photon laser-scanning confocal microscope system
-
批准号:7838159
-
项目类别:
-
资助金额:$120.05万
-
财政年份:2010
-
负责人:James Douglas Engel
-
依托单位:
The 16th Hemoglobin Switching Conference
-
批准号:7536929
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2008
-
负责人:James Douglas Engel
-
依托单位:
The 4th International Conference on GATA Factors and Human Disease
-
批准号:7331528
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:James Douglas Engel
-
依托单位:
海外基金